Literature DB >> 21436713

Dyslipidemia in an HIV-positive antiretroviral treatment-naive population in Dar es Salaam, Tanzania.

Catharina Armstrong1, Enju Liu, James Okuma, Donna Spiegelman, Chalamilla Guerino, Marina Njelekela, Steve Grinspoon, Wafaie Fawzi, Claudia Hawkins.   

Abstract

Limited data are available on dyslipidemia in HIV-infected patients in resource-limited settings. We performed a cross-sectional analysis in antiretroviral therapy (ART)-naive, non-fasting HIV-infected patients in Tanzania between November 2004 to June 2008. Robust linear regression modeling was performed. Lipid parameters were assessed in 12,513 patients [65% women; median (interquartile range) age, 36 (30-42) years; CD4 count, 143 (51-290) cells/mm]. Low high-density lipoprotein was prevalent in 67% and increased triglyceride in 28%. High triglyceride and low high-density lipoprotein levels were associated with low CD4 counts (P < 0.001). In this ART-naive Tanzanian population, dyslipidemia was highly prevalent and associated with advanced disease. The impact of ART on these changes requires further exploration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21436713      PMCID: PMC3125454          DOI: 10.1097/QAI.0b013e318219a3d1

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  31 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Trends in coronary artery disease and associated risk factors in sub-Saharan Africans.

Authors:  O Akinboboye; O Idris; O Akinboboye; O Akinkugbe
Journal:  J Hum Hypertens       Date:  2003-06       Impact factor: 3.012

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system.

Authors:  Virginia A Triant; Susan Regan; Hang Lee; Paul E Sax; James B Meigs; Steven K Grinspoon
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

5.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

6.  Increased de novo hepatic lipogenesis in human immunodeficiency virus infection.

Authors:  M K Hellerstein; C Grunfeld; K Wu; M Christiansen; S Kaempfer; C Kletke; C H Shackleton
Journal:  J Clin Endocrinol Metab       Date:  1993-03       Impact factor: 5.958

7.  Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.

Authors:  C Grunfeld; M Pang; W Doerrler; J K Shigenaga; P Jensen; K R Feingold
Journal:  J Clin Endocrinol Metab       Date:  1992-05       Impact factor: 5.958

8.  The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B.

Authors:  K R Feingold; R M Krauss; M Pang; W Doerrler; P Jensen; C Grunfeld
Journal:  J Clin Endocrinol Metab       Date:  1993-06       Impact factor: 5.958

9.  HIV infection and high density lipoprotein metabolism.

Authors:  Honor Rose; Jennifer Hoy; Ian Woolley; Urbain Tchoua; Michael Bukrinsky; Anthony Dart; Dmitri Sviridov
Journal:  Atherosclerosis       Date:  2007-12-04       Impact factor: 5.162

10.  Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome.

Authors:  C Grunfeld; D P Kotler; J K Shigenaga; W Doerrler; A Tierney; J Wang; R N Pierson; K R Feingold
Journal:  Am J Med       Date:  1991-02       Impact factor: 4.965

View more
  21 in total

1.  Models of integration of HIV and noncommunicable disease care in sub-Saharan Africa: lessons learned and evidence gaps.

Authors:  Benson Njuguna; Susan Vorkoper; Pragna Patel; Mike J A Reid; Rajesh Vedanthan; Colin Pfaff; Paul H Park; Lydia Fischer; Jeremiah Laktabai; Sonak D Pastakia
Journal:  AIDS       Date:  2018-07-01       Impact factor: 4.177

2.  Metabolic Profile of People Living with HIV in a Treatment Hub in Manila, Philippines: A Pre- and Post-Antiretroviral Analysis.

Authors:  Christian Francisco; Eddieson Gonzales; Marc Gregory Yu; Edsel Maurice Salvaña; Cybele Abad; Paul Ferdinand Reganit; Patricia Maningat; Olivia Sison; Marissa Alejandria
Journal:  J ASEAN Fed Endocr Soc       Date:  2022-02-18

3.  Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon.

Authors:  Dickson Shey Nsagha; Elroy Patrick Weledji; Nguedia Jules Clement Assob; Longdoh Anna Njunda; Elvis Asangbeng Tanue; Odette Dzemo Kibu; Charlotte Wenze Ayima; Marcelin Ngowe Ngowe
Journal:  BMC Cardiovasc Disord       Date:  2015-08-28       Impact factor: 2.298

4.  The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population.

Authors:  Cavin Epie Bekolo; Modestine Becker Nguena; Leonard Ewane; Patrick Sylvestre Bekoule; Basile Kollo
Journal:  BMC Public Health       Date:  2014-03-07       Impact factor: 3.295

5.  Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study.

Authors:  Zvenyika Ar Gomo; James G Hakim; Sarah A Walker; Willard Tinago; Gibson Mandozana; Cissy Kityo; Paula Munderi; Elly Katabira; Andrew Reid; Diana M Gibb; Charles F Gilks
Journal:  AIDS Res Ther       Date:  2014-10-02       Impact factor: 2.250

6.  Lower levels of high-density lipoprotein cholesterol in urban Africans presenting with communicable versus non-communicable forms of heart disease: the 'Heart of Soweto' hospital registry study.

Authors:  Jasmine G Lyons; Karen Sliwa; Melinda J Carrington; Frederick Raal; Sandra Pretorius; Friedrich Thienemann; Simon Stewart
Journal:  BMJ Open       Date:  2014-07-14       Impact factor: 2.692

7.  Cardiometabolic risk factors among HIV patients on antiretroviral therapy.

Authors:  James N Kiage; Douglas C Heimburger; Christopher K Nyirenda; Melissa F Wellons; Shashwatee Bagchi; Benjamin H Chi; John R Koethe; Donna K Arnett; Edmond K Kabagambe
Journal:  Lipids Health Dis       Date:  2013-04-10       Impact factor: 3.876

8.  Risk Factors of Cardiovascular Diseases in HIV/AIDS Patients on HAART.

Authors:  Dickson Shey Nsagha; Jules Clement Nguedia Assob; Anna Longdoh Njunda; Elvis Asangbeng Tanue; Odette Dzemo Kibu; Charlotte Wenze Ayima; Marcelin Ngowe Ngowe
Journal:  Open AIDS J       Date:  2015-10-20

9.  Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional survey.

Authors:  Nazisa Hejazi; Roslee Rajikan; Christopher Lee Kwok Choong; Suzana Sahar
Journal:  BMC Public Health       Date:  2013-08-15       Impact factor: 3.295

10.  Prevalence of Dyslipidemia Among Antiretroviral-Naive HIV-Infected Individuals in China.

Authors:  Yinzhong Shen; Jiangrong Wang; Zhenyan Wang; Tangkai Qi; Wei Song; Yang Tang; Li Liu; Renfang Zhang; Hongzhou Lu
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.